Medimmune FluMist Indication Could Exclude Patients With Asthma
Executive Summary
MedImmune could carve out a subpopulation of FluMist patients who suffer from wheezing and asthma from the proposed indication for the intranasal vaccine, the company said following receipt of a complete response letter from FDA